Protagenic Therapeutics Inc (PTIXW)
Official siteBIOTECHNOLOGY
Last updated: Apr 24, 2026 at 5:00 PM ET
Earnings
Key Metrics
Technical Indicators Dashboard
As of Nov 16, 2026, the price is 85.0% below its 50-day moving average, and the 50-day average is below the 200-day average. The 14-day RSI is 30.8, in the neutral range between 30 and 70.
Moving Averages
MACD
ADX
Aroon & PSAR
Bollinger Bands
RSI (14-Day)
Momentum Oscillators
Volatility Measures
Volume Flow
Volume Metrics
Pivot Points
Advanced Oscillators
Financial Performance
Related GNG Research
No research available
Be the first to write about PTIXW
News
No news available
Company news will appear here when available
Protagenic Therapeutics Competitors
Peers by sector and size for Protagenic Therapeutics (PTIXW) include NeuroSense Therapeutics Ltd. Warrant, Jasper Therapeutics and Biofrontera Inc. Warrants.
Sector: Healthcare
Updated Mar 10, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology
Frequently Asked Questions About PTIXW
Does PTIXW pay dividends?
Protagenic Therapeutics Inc (PTIXW) does not currently pay a regular dividend.
PTIXW pages: Overview, Financials
Get full access to GNG Research
Create a free account to access portfolio tracking, advanced tools, and more.